Compare TTK HEALTHCARE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DIVIS LABORATORIES TTK HEALTHCARE/
DIVIS LABORATORIES
 
P/E (TTM) x 12.1 57.8 21.0% View Chart
P/BV x 1.8 15.4 11.4% View Chart
Dividend Yield % 0.9 0.4 221.4%  

Financials

 TTK HEALTHCARE   DIVIS LABORATORIES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
DIVIS LABORATORIES
Mar-19
TTK HEALTHCARE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,2151,639 74.1%   
Low Rs6101,115 54.7%   
Sales per share (Unadj.) Rs444.4186.3 238.5%  
Earnings per share (Unadj.) Rs17.251.0 33.8%  
Cash flow per share (Unadj.) Rs27.657.3 48.2%  
Dividends per share (Unadj.) Rs5.0016.00 31.3%  
Dividend yield (eoy) %0.51.2 47.2%  
Book value per share (Unadj.) Rs177.9261.8 68.0%  
Shares outstanding (eoy) m14.13265.47 5.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.17.4 27.8%   
Avg P/E ratio x52.927.0 195.8%  
P/CF ratio (eoy) x33.024.0 137.5%  
Price / Book Value ratio x5.15.3 97.5%  
Dividend payout %29.031.4 92.3%   
Avg Mkt Cap Rs m12,894365,592 3.5%   
No. of employees `0002.311.8 19.5%   
Total wages/salary Rs m1,3075,423 24.1%   
Avg. sales/employee Rs Th2,715.74,175.1 65.0%   
Avg. wages/employee Rs Th565.3457.7 123.5%   
Avg. net profit/employee Rs Th105.41,141.8 9.2%   
INCOME DATA
Net Sales Rs m6,27949,463 12.7%  
Other income Rs m781,556 5.0%   
Total revenues Rs m6,35651,019 12.5%   
Gross profit Rs m49618,718 2.6%  
Depreciation Rs m1471,689 8.7%   
Interest Rs m3435 96.6%   
Profit before tax Rs m39318,551 2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1495,023 3.0%   
Profit after tax Rs m24413,527 1.8%  
Gross profit margin %7.937.8 20.9%  
Effective tax rate %37.927.1 140.1%   
Net profit margin %3.927.3 14.2%  
BALANCE SHEET DATA
Current assets Rs m2,71746,501 5.8%   
Current liabilities Rs m1,5718,468 18.6%   
Net working cap to sales %18.376.9 23.7%  
Current ratio x1.75.5 31.5%  
Inventory Days Days32131 24.6%  
Debtors Days Days4786 54.3%  
Net fixed assets Rs m99125,797 3.8%   
Share capital Rs m141531 26.6%   
"Free" reserves Rs m2,37368,962 3.4%   
Net worth Rs m2,51469,493 3.6%   
Long term debt Rs m30-   
Total assets Rs m4,15880,383 5.2%  
Interest coverage x12.6531.0 2.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.50.6 245.4%   
Return on assets %6.716.9 39.6%  
Return on equity %9.719.5 49.8%  
Return on capital %16.926.7 63.3%  
Exports to sales %3.60-   
Imports to sales %0.524.6 2.0%   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m3112,187 0.3%   
Fx inflow Rs m22541,238 0.5%   
Fx outflow Rs m7112,405 0.6%   
Net fx Rs m15428,833 0.5%   
CASH FLOW
From Operations Rs m1739,543 1.8%  
From Investments Rs m97-6,854 -1.4%  
From Financial Activity Rs m-307-2,459 12.5%  
Net Cashflow Rs m-38230 -16.4%  

Share Holding

Indian Promoters % 65.4 52.0 125.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.8 31.4%  
FIIs % 5.2 19.0 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.2 150.0%  
Shareholders   12,723 31,796 40.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 17, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ALEMBIC COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS